Drugmakers will sell the HIV prevention injection for 100 times the price of gold, so SA won’t be able to buy it even though the country was part of clinical trials to test it. | Bhekisisa_MG
It should be a standard requirement that any drug company that wants to test its inventions in the country must also opt in to giving the country’s people access to it at a reasonable priceSome might say that the drug industry proved its benevolence during the Covid pandemic.struck a dealBut that didn’t mean J&J shared all of its trade secrets, rather that Aspen can import the ingredient that makes the vaccine work and just complete the steps after that.
After facing wide criticism about the move, J&J and the EU sent the shipment back to the AU. J&J has since signed a new, adjusted agreement with, but the run of events does illustrate the nature of some of these contracts where powerful corporations can impose restrictive conditions that stifle the independence of smaller manufacturers.
SA cannot allow this type of deal to play out again. It should instead be a standard requirement that any drug company that wants to test its inventions in the country must also opt in to giving the country’s people access to it at a reasonable price. This must be built into the R&D process as early as possible to ensure that the fruits of innovation are benefiting the greatest number of people.Patients volunteering for clinical studies make a significant contribution to science. They deserve to have their voices heard in decisions made about data and results sharing — especially with whom the data is shared and under which terms they can get access to health technology being trialled.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Deal reached for generic drug to prevent HIV infectionSome 1.5 million new infections occurred last year –- more than a million over global targets of fighting the virus.
Read more »
SPOTLIGHT: Experts welcome new HIV drug formulations that cut out the ‘ew’ factor for childrenNew child-friendly formulations of several important antiretroviral medicines were recently approved by the South African Health Products Regulatory Authority. Thabo Molelekwa asks what this means for children living with HIV in South Africa and how long it will take for these medicines to become widely available.
Read more »
SA population grows despite Covid-19, high HIV rate'The social and economic effect of losing so many elderly people to the Covid-19 pandemic is likely to be felt in many years to come,' says Stats SA.
Read more »
Why black shareholding in SA banks is declining - and may continue to fall | Fin24Black ownership of banks remained flat between 2019 and 2020, but the picture changes if you track it from 2016. Black management control is falling short of targets across the board.
Read more »
Busisiwe Mavuso | Why energy reforms will benefit SA beyond just ending load shedding | Fin24Energy reforms announced by President Cyril Ramaphosa this week could have a dramatic impact on South Africa's growth prospects, even excluding the upside that will come when load shedding ends, writes Busisiwe Mavuso.
Read more »
Thabo Mbeki should account for HIV/Aids deaths: Corruption WatchCorruption Watch has taken a jab at former president Thabo Mbeki over his piercing critique of the government and says he should acknowledge state capture and Aids denialism started during his era.
Read more »